ASND

Ascendis Pharma A/S

Jun 23 • 04:00PM ET

238.59

+10.59 4.64 %

Healthcare • Biotechnology • Denmark • Large • NASD

Peers: BMRN VRTX IONS REGN ALNY EXEL INCY RARE CRSP NBIX

| Held by: IBB TCAF SQS SPDW FDG AFOS QQQJ MEDI MSSM TMSL

Scroll to Statements

Index	-	P/E	26.89	EPS (ttm)	8.87	Insider Own	0.89%	Shs Outstand	62.11M	Perf Week	6.85%
Market Cap	14.82B	Forward P/E	21.89	EPS next Y	10.90	Insider Trans	-3.19%	Shs Float	61.56M	Perf Month	-3.60%
Enterprise Value	15.19B	PEG	-	EPS next Q	1.74	Inst Own	102.03%	Short Float	2.79%	Perf Quarter	9.41%
Income	581.90M	P/S	14.74	EPS this Y	460.89%	Inst Trans	-44.75%	Short Ratio	2.60	Perf Half Y	19.41%
Sales	1.01B	P/B	26.36	EPS next Y	-29.45%	ROA	33.69%	Short Interest	1.72M	Perf YTD	11.89%
Book/sh	9.05	P/C	22.45	EPS next 5Y	-	ROE	325.80%	52W High	250.74 -4.85%	Perf Year	35.73%
Cash/sh	10.63	P/FCF	293.04	EPS past 3/5Y	27.03% 14.76%	ROIC	57.78%	52W Low	160.86 48.32%	Perf 3Y	170.54%
Dividend Est.	-	EV/EBITDA	1124.50	Sales past 3/5Y	147.23% 152.45%	Gross Margin	87.35%	Volatility	4.67% 4.13%	Perf 5Y	71.93%
Dividend TTM	-	EV/Sales	15.11	EPS Y/Y TTM	249.36%	Oper. Margin	-0.66%	ATR (14)	9.50	Perf 10Y	1621.43%
Dividend Ex-Date	-	Quick Ratio	0.72	Sales Y/Y TTM	155.14%	Profit Margin	57.88%	RSI (14)	59.73	Recom	1.10
Dividend Gr. 3/5Y	- -	Current Ratio	1.00	EPS Q/Q	787.72%	SMA20	6.91%	Beta	0.37	Target Price	291.53
Payout	-	Debt/Eq	1.84	Sales Q/Q	171.53%	SMA50	3.08%	Rel Volume	1.27	Prev Close	228.00
Employees	-	LT Debt/Eq	0.79	Earnings	May 07 BMO	SMA200	9.36%	Avg Volume	662.07K	Price	238.59
IPO	Jan 28, 2015	Option/Short	Yes / Yes	EPS/Sales Surpr.	5921.98% -7.60%	Trades		Volume	835,887	Change	4.64%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)